Thy1-GCaMP6 transgenic mice for neuronal population imaging in vivo.
Dana H, Chen TW, Hu A, Shields BC, Guo C, Looger LL, Kim DS, Svoboda K. · 2014
Read Thy1-GCaMP6 transgenic mice for neuronal population imaging in vivo. by Dana H, Chen TW, Hu A, Shields BC, Guo C, Looger LL, Kim DS, Svoboda K. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4177405.txt.
Introduction
Hod Dana, Karel Svoboda, and seven co-authors built a new kind of imaging mouse and reported it in PLoS ONE in 2014. Brain researchers watch nerve cells fire by using proteins that glow when calcium rises. Getting those proteins into the brain usually means injecting a virus, which gives uneven and short-lived results.
The team bred mice that carry the sensor protein GCaMP6 in their own genes, switched on in nerve cells by the Thy1 promoter. Three mouse lines were tested for imaging in the visual cortex of living animals, and their signals matched or beat virus-injected mice. Because every cell carries the sensor from birth, the same cells can be watched for long stretches, even while the mice move and behave.
Catalog record
| CREATOR | Dana H, Chen TW, Hu A, Shields BC, Guo C, Looger LL, Kim DS, Svoboda K. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Thy1-GCaMP6 Transgenic Mice for Neuronal Population Imaging In Vivo By Hod Dana, Tsai-Wen Chen, Amy Hu, Brenda C Shields, Caiying Guo, Loren L Looger, Douglas S Kim, Karel Svoboda, Benjamin Arenkiel Published in: PLoS ONE DOI: 10.1371/journal.pone.0108697 ABSTRACT Abstract Genetically-encoded calcium indicators (GECIs) facilitate imaging activity of genetically defined neuronal populations in vivo. The high intracellular GECI concentrations required for in vivo imaging are usually achieved by viral gene transfer using adeno-associated viruses. Transgenic expression of GECIs promises important advantages, including homogeneous, repeatable, and stable expression without the need for invasive virus injections. Here we present the generation and characterization of transgenic mice expressing the GECIs GCaMP6s or GCaMP6f under the Thy1 promoter. We quantified GCaMP6 expression across brain regions and neurons and compared to other transgenic mice and AAV-mediated expression. We tested three mouse lines for imaging in the visual cortex in vivo and compared their performance to mice injected with AAV expressing GCaMP6. Furthermore, we show that GCaMP6 Thy1 transgenic mice are useful for long-term, high-sensitivity imaging in behaving mice. INTRODUCTION Optical imaging of calcium dynamics is commonly used for monitoring activity in neuronal ensembles and micro-compartments. For example, using 2-photon microscopy the activity of hundreds of cells has been measured during behavior [1], [2]. Continued development of genetically encoded calcium indicators (GECIs) has enabled a shift from synthetic indicators, such Fluo-4 and Oregon Green BAPTA-1 [3], to protein indicators [4], [5], [6], [7], [8], [9]. GECIs can be introduced to the brain using relatively noninvasive gene transfer methods such as viral infection using adeno-associated viruses (AAVs) [4], [10]. Neurons expressing GECIs can be monitored over weeks [1], [4], [9], [11]. The recently developed GCaMP6 indicators allow sensitive detection of activity, under favorable circumstances down to single action potentials (APs) [7]. AAVs can produce the high intracellular GECI concentrations (∼10–100 µM) required for in vivo imaging [1], [12]. However, AAVs produce different expression levels in neighboring neurons and gradients in expression levels across the infection site [4], [7]. In addition, GECI expression levels continue to rise over time until they can cause aberrant cell health [4], [12]. The time window for GECI imaging is thus typically limited to a few weeks, depending on the promoter construct, viral titer, injection volume, and other factors. Finally, AAV-mediated gene transfer requires challenging surgeries. Best-practice procedures demand tiny injection volumes (approximately 50 nl) [1], which can result in variable numbers of infected cells with variable GECI expression levels. Transgenic methods can produce stable expression of GECIs over longer time scales [12], [13], [14], potentially over the entire lifetime of the mouse, without invasive procedures for gene transfer. Expression patterns and levels are reproducible across different individual animals [12]. Several transgenic GECI mouse lines have been developed [12], [13], [14], [15], [16], [17], [18], [19], [20], which have demonstrated the advantages of transgenic control of protein expression. Here we present the development and characterization of transgenic mouse lines expressing GCaMP6s and GCaMP6f GECIs under the Thy1 promoter [20], [21], [22]. We characterize the brain-wide expression patterns of each line, and the performance of selected lines for cellular in vivo imaging. MATERIALS AND METHODS All surgical and experimental procedures were in accordance with protocols approved by the Janelia Farm Institutional Animal Care and Use Committee and Institutional Biosafety Committee. Transgenic mice Here we report on GENIE Project (GP) lines GP4.x (where ‘x’ refers to the founder number) expressing GCaMP6s, and GP5.x expressing GCaMP6f. Thy1-GCaMP6-WPRE transgenic mice were generated using standard techniques [23].We included the WPRE (Woodchuck hepatitis virus post-transcriptional regulatory element), which increases mRNA stability and protein expression [24], [25]. Genotyping primers were 5′-CATCAGTGCAGCAGAGCTTC-3′ (forward, anneals to calmodulin sequence in GCaMP6) and 5′-CAGCGTATCCACATAGCGTA-3′ (reverse, anneals to WPRE sequence). Mouse lines GP4.3, 4.12, 5.5, 5.11 and 5.17 were deposited at The Jackson Laboratory (acquisition numbers provided at end). Expression analysis Adult mice (P42–P56) were deeply anesthetized with isofluorane and transcardially perfused with 10 ml 1× Dulbecco's phosphate-buffered saline (DPBS, Life Technologies), followed by 50 ml 4% paraformaldehyde in 0.1 M phosphate buffer. After perfusion, the brains were removed and post-fixed overnight at 4°C. The brains were embedded in 5% agarose in DPBS, and cut into 50 µm thick coronal sections with a vibratome (Leica VT 1200S). Since DPBS contains a saturating concentration of calcium (0.9 mM) GCaMP brightness will be maximal. Every other section was dehydrated with DPBS and coverslipped with Vectashield mounting medium (H-1400, Vector laboratories). The coverslipped sections were imaged using a slide scanner (Nanozoomer, Hamamatsu). Confocal images (LSM 710, Zeiss) were collected for selected brain regions (Fig. 1 and 2, Fig. S1 and S3) [26], using an 20× 0.8 NA objective and standard GFP imaging filters. Individual images were tiled and stitched using commercial software (Zeiss). [Figure: Thy1 transgenic mice expressing GCaMP6s or GCaMP6f. a. Schematic of the transgene cassettes used to generate GP4.x (top) and GP5.x (bottom) lines. WPRE = Woodchuck hepatitis virus post-transcriptional regulatory element, pA = poly-adenylation tail. b. Wide-field images of coronal sections showing GCaMP fluorescence in various transgenic lines. c. Representative confocal images (tiled and stitched to show larger field of view) from the somatosensory cortex of the same lines as in b. All images show GCaMP6 fluorescence.] [Figure: Stable GCaMP expression in GP mice over months. a. Confocal microscope images of fixed coronal sections from the motor cortex of GP5.17 mice at different ages (F1- first generation, F2- second generation). b. Somatic GCaMP6f brightness for all neurons inside the white rectangles in a (51–65 neurons from each animal). For each mouse, the box indicates the 25th to 75th percentile distribution, red line indicates the median, and whisker length is 150% of the 25th to 75th percentile distance, or until it touches the last sample position. Outliers are marked in red crosses. c. In vivo two-photon microscopy images of GP4.3 mice taken at different days after cranial window implantation show similar expression pattern without filled nuclei. Arrowheads point to three individual cells in both images.] For a subset of mouse lines (GP4.3, GP4.12, GP5.5, GP5.11, and GP5.17) we visualized neurons using NeuN to measure the fraction of neurons expressing GCaMP. Staining was performed on sections that were not used for quantification of expression. Sections were blocked with 2% BSA and 0.4% Triton X-100 solution for 1 hour at room temperature to prevent nonspecific antibody binding, followed by incubation overnight at 4°C with mouse anti-NeuN primary antibody (1∶500; Millipore, MAB 377) and incubation with Alexa594-conjugated goat-anti-mouse secondary antibody (1∶ 500; Life Technologies, A11032) for 4 hours at room temperature. Sections were mounted on microscope slides with Vectashield mounting medium (H-1400, Vector laboratories). We analyzed primary motor cortex (M1), primary somatosensory cortex (S1), primary visual cortex (V1) and hippocampus (CA1, CA3, and Dentate Gyrus, DG) using confocal microscopy. For sample images in each area we identified all labeled cells, segmented their somata, and calculated the somatic GCaMP fluorescence brightness for each cell. For cortical regions, cells were grouped into layer 2/3 (L2/3) and layer 5 (L5) cells. We also counted the fraction of GCaMP labeled cells (green channel) as a fraction of the NeuN stained cells (red channel). To compensate for variations of imaging conditions across time (e.g. changes in the excitation light source intensity), images of a fluorescence